The AAIC will have the participation of Ace Alzheimer Center Barcelona
The Ace Research Unit will present the latest developments in Alzheimer's disease genetics and biomarkers for early detection at the Alzheimer's Association International Conference.
Dr. Sergi Valero, Deputy Director of Research at Ace, presents the poster "Predictive value of the Alzheimer Polygenic Risk Score on Cognitive Decline in Patients with Alzheimer's Disease Dementia", the first study that demonstrates the predictive capacity of the polygenic risk score in progression from cognitive decline to Alzheimer's disease.
Dr. Marta Marquié, neurologist and head of Ace's Artificial Intelligence and Big Data program, presents the virtual poster “Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort ”. The NORFACE cohort studies the relationship between retinal thickness and cognitive impairment.
In addition to taking a poster and an oral presentation, Dr. Amanda Cano, head of Ace's Biomarkers and Molecular Biology subprogram, will chair the session "The prognostic utility of blood-based biomarkers", which will be held on July 20 at 11:30 a.m.
Dr. Cano also presents the following posters:
- Proteomic analysis reveal early differences in plasma exosomes of Aβ(+) vs Aβ(-) patients with early-onset mild cognitive impairment: from BIOFACE to BIOPEXAL study.
- (Oral) Diagnostic performance and clinical applicability of plasma pTau181 to predict dementia risk in a large real-world cohort of a memory clinic.
For his part, Pablo García, Ace predoctoral researcher, presents the poster “PSP/DEGESCO: A Progressive Supranuclear Palsy Genome-Wide Association Study in the Spanish Population”
Finally, Raquel Puerta, Ace predoctoral researcher, presents the poster “Head-to-head comparison of aptamer- and antibody-based proteomic platforms in CSF samples of a real-world large cohort of a memory clinic”
The Alzheimer's Association International Conference (AAIC) is the reference conference for the dementia research community.
This year it is held from July 16 to 20 in Amsterdam, the Netherlands.